PETALING JAYA: Malaysia's private healthcare players are expected to see a continuous uptrend in inpatient admissions, more complex cases and patients traveling from abroad to obtain medical treatment here.
Maybank Investment Bank (Maybank IBG) Research said while it is cautious on risks of unfavourable regulatory changes, it believes that market has priced in the negatives ahead of fundamentals as implementation of diagnosis-related group (DRG) can only roll out beyond 2025.
